Cite
HARVARD Citation
Breitkreutz, I. et al. (n.d.). Dose‐intensified bendamustine followed by autologous peripheral blood stem cell support in relapsed and refractory multiple myeloma with impaired bone marrow function. Hematological oncology. 34 (4), pp. 200-207. [Online].